A CALHM1 Polymorphism Associated with Late-Onset Alzheimer's Disease Predicts Elevations in CSF Aβ1-40 and Aβ1-42 in Healthy Normal Controls

被引：0
|
作者：
Koppel, Jeremy [1 ]
机构：
[1] Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY USA
来源：
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY | 2009年 / 17卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：A105 / A106
页数：2
相关论文
共 50 条
  • [1] CALHM1 Polymorphism is not Associated with Late-onset Alzheimer Disease
    Beecham, Gary W.
    Schnetz-Boutaud, Nathalie
    Haines, Jonathan L.
    Pericak-Vance, Margaret A.
    ANNALS OF HUMAN GENETICS, 2009, 73 : 379 - 381
  • [2] CALHM1 P86L Polymorphism Is Associated with Late-Onset Alzheimer's Disease under a Recessive Model
    Boada Rovira, Merce
    Antunez Almagro, Carmen
    Lopez-Arrieta, Jesus
    Jorge Galan, Jose
    Moron, Francisco J.
    Hernandez Ruiz, Isabel
    Marin, Juan
    Martinez-Lage, Pablo
    Carrasco, Jose M.
    Real, Luis M.
    Gonzalez-Perez, Antonio
    Tarraga Mestre, Lluis
    Ruiz, Agustin
    NEUROLOGY, 2010, 74 (09) : A268 - A268
  • [3] CALHM1 P86L Polymorphismis Associated with Late-Onset Alzheimer's Disease in a Recessive Model
    Boada, Merce
    Antunez, Carmen
    Lopez-Arrieta, Jesus
    Jorge Galan, Jose
    Moron, Francisco J.
    Hernandez, Isabel
    Marin, Juan
    Martinez-Lage, Pablo
    Alegret, Montserrat
    Carrasco, Jose M.
    Moreno, Concha
    Real, Luis M.
    Gonzalez-Perez, Antonio
    Tarraga, Lluis
    Ruiz, Agustin
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (01) : 247 - 251
  • [4] Combination assay of CSF Tau, Aβ1-40 and Aβ1-42(43) as a biochemical marker of Alzheimer's disease
    Shoji, M
    Matsubara, E
    Kanai, M
    Watanabe, M
    Nakamura, T
    Tomidokoro, Y
    Shizuka, M
    Wakabayashi, K
    Igeta, Y
    Ikeda, Y
    Mizushima, K
    Amari, M
    Ishiguro, K
    Kawarabayashi, T
    Harigaya, Y
    Okamoto, K
    Hirai, S
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 158 (02) : 134 - 140
  • [5] Plasma membrane cholesterol controls the cytotoxicity of Alzheimer's disease AβP (1-40) and (1-42) peptides
    Arispe, N
    Doh, M
    FASEB JOURNAL, 2002, 16 (12): : 1526 - 1536
  • [6] CALHM1 P861 Polymorphism Modulates CSF Aβ Levels in Cognitively Healthy Individuals at Risk for Alzheimer's Disease
    Koppel, Jeremy
    Campagne, Fabien
    Vingtdeux, Valerie
    Dreses-Werringloer, Ute
    Ewers, Michael
    Rujescu, Dan
    Hampel, Harald
    Gordon, Marc L.
    Christen, Erica
    Chapuis, Julien
    Greenwald, Blaine S.
    Davies, Peter
    Marambaud, Philippe
    MOLECULAR MEDICINE, 2011, 17 (9-10) : 974 - 979
  • [7] CALHM1 variant is not associated with Alzheimer's disease among Asians
    Tan, E. K.
    Ho, P.
    Cheng, S. Y.
    Yih, Yuen
    Li, H. H.
    Fook-Chong, S.
    Lee, W. L.
    Zhao, Yi
    NEUROBIOLOGY OF AGING, 2011, 32 (03) : 546.e11 - 546.e12
  • [8] CALHM1 P86L Polymorphism Modulates CSF Aβ Levels in Cognitively Healthy Individuals at Risk for Alzheimer’s Disease
    Jeremy Koppel
    Fabien Campagne
    Valérie Vingtdeux
    Ute Dreses-Werringloer
    Michael Ewers
    Dan Rujescu
    Harald Hampel
    Marc L. Gordon
    Erica Christen
    Julien Chapuis
    Blaine S. Greenwald
    Peter Davies
    Philippe Marambaud
    Molecular Medicine, 2011, 17 : 974 - 979
  • [9] Plasma Aβ1-40 and Aβ1-42 levels and the risk of Alzheimer's disease in the cardiovascular health study
    Lopez, Oscar L.
    Kuller, Lewis H.
    Mehta, Pankaj
    Becker, James T.
    Sweet, Robert A.
    Gach, Michael H.
    Tracy, Russell
    DeKosky, Steven T.
    NEUROLOGY, 2007, 68 (12) : A170 - A171
  • [10] No association between CALHM1 polymorphism and Alzheimer's disease risk in a Hungarian population
    Feher, Agnes
    Juhasz, Anna
    Rimanoczy, Agnes
    Pakaski, Magdolna
    Kalman, Janos
    Janka, Zoltan
    PSYCHIATRIC GENETICS, 2011, 21 (05) : 249 - 252
12345